Fig. 6From: Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancerThe mass spectra of four active components in SH003. A hispidulin B Luteolin C Baicalein D ChrysoeriolBack to article page